| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/04/2010 | WO2010012039A1 Process for recovering proteins from crustacean exoskeletons |
| 02/04/2010 | US20100031400 Polypeptides having acetylxylan esterase activity and polynucleotides encoding same |
| 02/04/2010 | US20100031399 Polypeptides having alpha-glucuronidase activity and polynucleotides encoding same |
| 02/04/2010 | US20100029571 Novel and powerful mhc-class ii peptides derived from survivin |
| 02/04/2010 | US20100029562 hG31P Expression System |
| 02/04/2010 | US20100029555 G-csf site-specific mono-conjugates |
| 02/04/2010 | US20100029548 Glycoproteins produced in plants and methods of their use |
| 02/04/2010 | US20100029547 Mvl, an antiviral protein from a cyanobacterium |
| 02/04/2010 | US20100028993 Methods of producing peptides in plants and peptides produced thereby |
| 02/04/2010 | US20100028952 Fermentation and purification of actinomadura chromoprotein and related species |
| 02/04/2010 | US20100028951 Production of glycoproteins with modified fucosylation |
| 02/04/2010 | US20100028950 Method for the immobilization of biologically active polypeptides by using maltose binding protein |
| 02/04/2010 | US20100028949 Shrna-mediated inhibition of expression of alpha 1,6-fucosyltransferase |
| 02/04/2010 | US20100028948 nucleic acids encoding antibodies which immunospecifically bind to one or more respiratory syncytial virus (RSV) antigens |
| 02/04/2010 | US20100028947 Use of human cells of myeloid leukaemia origin for expression of antibodies |
| 02/04/2010 | US20100028946 Fusion partner cells |
| 02/04/2010 | US20100028945 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor |
| 02/04/2010 | US20100028944 Methods of obtaining genetic competence in bacillus cells |
| 02/04/2010 | US20100028943 Modified Messenger RNA Stabilizing Sequences for Expressing Genes in Bacterial Cells |
| 02/04/2010 | US20100028942 Methods for Improving Viability and Productivity in Cell Culture |
| 02/04/2010 | US20100028941 Method for Multiparallel Construction of Host/Vector-Systems for Expression of Proteins |
| 02/04/2010 | US20100028940 Compositions and Methods for Metabolic Selection of Transfected Cells |
| 02/04/2010 | US20100028939 Use of Galactose Oxidase for Selective Chemical Conjugation of Protractor Molecules to Proteins of Therapeutic Interest |
| 02/04/2010 | US20100028910 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity |
| 02/04/2010 | US20100028905 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 02/04/2010 | US20100028415 Method of Inducing Neutralizing Antibodies to Human Immunodeficiency Virus |
| 02/04/2010 | US20100028386 Recombinant p. falciparum merozoite protein-142 vaccine |
| 02/04/2010 | US20100028384 Yeast expressed classical swine fever virus glycoprotein e2 and use thereof |
| 02/04/2010 | US20100028378 Toxin-antitoxin system and applications thereof |
| 02/04/2010 | US20100028375 Vlp based vaccine delivery system |
| 02/04/2010 | US20100028374 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 02/04/2010 | US20100028367 Sgp130/fc dimers |
| 02/04/2010 | US20100028359 Antibodies to receptor of advanced glycation end products (rage) and uses thereof |
| 02/04/2010 | US20100028351 Anti-amyloid antibodies, compositions, methods and uses |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028347 Antibodies against vascular endothelial growth factor receptor-1 |
| 02/04/2010 | US20100028343 for treating degenerative cartilaginous disorders and other inflammatory diseases; interleukin-17 receptor protein |
| 02/04/2010 | US20100028341 Amino acid sequences that modulate the interaction between cells of the immune system |
| 02/04/2010 | US20100028340 Antibodies against the rgm a protein and uses thereof |
| 02/04/2010 | US20100028330 Methods of upmodulating adaptive immune response using anti-pd1 antibodies |
| 02/04/2010 | US20100028327 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/04/2010 | CA2732082A1 Family 6 cellulase with decreased inactivation by lignin |
| 02/04/2010 | CA2732003A1 Antibodies that neutralize botulinum neurotoxins |
| 02/04/2010 | CA2731203A1 Constructs and methods for the production and secretion of polypeptides |
| 02/03/2010 | EP2149609A1 Improved process for the production of daptomycin |
| 02/03/2010 | EP2149604A1 Collections of repeat proteins comprising repeat modules |
| 02/03/2010 | EP2149381A2 Method of treating malignancies through induction of blood immune responses |
| 02/03/2010 | EP2148929A1 Anti-tissue factor antibodies and compositions with enhanced effector function |
| 02/03/2010 | CN101638681A Two aqueous phase extraction method for ocean pearl shell aminoglycoside |
| 02/03/2010 | CN101638437A Growth hormone fusion protein |
| 02/03/2010 | CN100586481C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/02/2010 | US7657380 Methods of generating variant antibodies with increased host string content |
| 02/02/2010 | US7655783 Methods and compositions for increasing antibody production |
| 02/02/2010 | US7655781 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
| 02/02/2010 | US7655775 Recombinant vectors for treating E coli infections more specifically those that result in post weaning diarrhea or scours; lactic acid bacterium |
| 02/02/2010 | US7655772 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders |
| 02/02/2010 | US7655771 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 02/02/2010 | US7655760 Antibodies to the polypeptide hormone phosphatonin |
| 02/02/2010 | US7655759 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains |
| 02/02/2010 | US7655617 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 02/02/2010 | US7655463 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 02/02/2010 | US7655458 Endostatin for use in the treatment of cancer and tumor metastasis |
| 02/02/2010 | US7655452 Brevibacillus choshinensis and process for prodcuing protein wtih use of the microbe as host |
| 02/02/2010 | US7655450 Efficient production of an optically active amino acid; Arthrobacter; culturing |
| 02/02/2010 | US7655447 ZSIG33-like polynucleotides |
| 02/02/2010 | US7655441 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/02/2010 | US7655439 Trimerizing polypeptides |
| 02/02/2010 | US7655438 Antisense polynucleotide; cancer; polypeptide comprising the protein encoded by the polynucleotide sequence |
| 02/02/2010 | US7655437 Enables an expression level equal to or higher than 52% of the recombinant hG-CSF to the total proteins after expression; useful in hematology and oncology |
| 02/02/2010 | US7655435 For eukaryotic in vitro expression; silicone-based surfactants and microcapsules; phage display |
| 02/02/2010 | US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES |
| 02/02/2010 | US7655417 VCAM-1 specific monoclonal antibody |
| 02/02/2010 | US7655413 Methods and compositions for enhanced protein expression and purification |
| 02/02/2010 | US7655406 Expression vector comprising nucleotide sequences coding non-structural proteins of hepatitis virus for use in identifying modulators which prevent viral infections |
| 02/02/2010 | US7655246 Chlamydia protein, gene sequence and uses thereof |
| 02/02/2010 | US7655245 Meningococcal serotype polypepties for use in diagnosis, prevention and treatment of microorganismal infection |
| 02/02/2010 | US7655241 Methods and compositions for vaccination against or involving enterobacteriaceae bacteria |
| 02/02/2010 | US7655239 Peptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/02/2010 | US7655232 Monoclonal antibody for use in prevention and treatment of osteoarthritic and surgical pain; immunotherapy |
| 02/02/2010 | US7655231 Methods for treating pain by administering a nerve growth factor antagonist and an NSAID |
| 02/02/2010 | US7655228 Ganglioside (GD3) specific immunoglobulin for diagnosis, prevention and treatment of cell proliferative disorders |
| 02/02/2010 | US7655227 Using a substance capable of inhibiting the binding between parathyroid hormone-related peptide (PTHrP) and a receptor; humanized anti-parathyroid hormone related protein 1-34 (anti-PTHrP (1-34)) antibody |
| 02/02/2010 | US7655223 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 02/02/2010 | CA2479494C Compositions and methods associated with pro5725 and its use for the diagnosis of lung and colon tumor |
| 02/02/2010 | CA2459489C Method for diagnosing or monitoring carbohydrate metabolism disorders |
| 02/02/2010 | CA2439051C Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 02/02/2010 | CA2428214C Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 02/02/2010 | CA2427029C Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 02/02/2010 | CA2387473C Improved method for the detection of acid resistant microorganisms in a stool |
| 02/02/2010 | CA2366468C Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 02/02/2010 | CA2355893C Antiuracil monoclonal antibody |
| 02/02/2010 | CA2327524C Method of controlling cleavage by ompt protease |
| 02/02/2010 | CA2302779C Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 02/02/2010 | CA2293724C Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 02/02/2010 | CA2272573C Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a methodof detecting auto-immune antibodies |
| 02/02/2010 | CA2180425C Purified primate ctla-8 antigens and related reagents |
| 02/02/2010 | CA2146974C Direct selection of cells by secretion product |
| 02/02/2010 | CA2142331C Immunoglobulins devoid of light chains |
| 02/01/2010 | CA2674257A1 Improved process for the production of daptomycin |
| 01/28/2010 | WO2010011957A2 Enzymatic hydrolysis of cellulosic biomass through enhanced removal of oligomers |